USPTO Examiner RASSAVONG ERIC - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18816428SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSAugust 2024August 2025Allow1120YesNo
18816593SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSAugust 2024March 2026Abandon2630YesNo
18646438SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSApril 2024September 2024Allow520NoNo
18646372SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSApril 2024August 2024Allow420NoNo
18635828NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES AND METHODS WITH INTEGRATED ELECTRONICSApril 2024March 2025Allow1100NoNo
18619012SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSMarch 2024September 2024Allow540NoNo
18597616SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSMarch 2024July 2024Allow430NoNo
18399859SPRING-TENSIONED ARTICULABLE CATHETERDecember 2023September 2024Allow900NoNo
18386190MULTIPLE DRESSING NEGATIVE PRESSURE WOUND THERAPY SYSTEMNovember 2023February 2025Allow1600YesNo
18497227SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSOctober 2023December 2023Allow200NoNo
18495402SYSTEM AND METHOD FOR WOUND TREATMENT AND IRRIGATIONOctober 2023June 2025Allow2020NoNo
18464474COLLECTING UNIT FOR MEDICAL SUCTIONS WITH A FOLDED BAGSeptember 2023September 2024Allow1200NoNo
18453793SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSAugust 2023November 2023Allow300NoNo
18450806ARTICULABLE CATHETER FOR CHANNELING BODY FLUIDS AND OBJECTSAugust 2023November 2023Allow300YesNo
18359370SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJuly 2023November 2023Allow400NoNo
18342553SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJune 2023March 2024Allow810NoNo
18342480SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJune 2023September 2023Allow300NoNo
18329433SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJune 2023December 2023Allow710NoNo
18329414SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJune 2023October 2023Allow410NoNo
18329450SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJune 2023February 2024Allow910YesNo
18308905VALVESApril 2023August 2025Allow2810NoNo
18140432SYSTEMS, DEVICES, AND METHODS FOR REPLACING AN EYEDROPPER TIP ON AN EYEDROPPER BOTTLE WITH A REPLACEMENT EYEDROPPER TIPApril 2023October 2025Allow2910NoNo
18139090ISOLATING DRAINAGE CATHETERApril 2023March 2025Abandon2310NoNo
18296825METHODS, SYSTEMS, AND COMPOSITIONS FOR MAINTAINING FUNCTIONING DRAINAGE BLEBS ASSOCIATED WITH MINIMALLY INVASIVE MICRO SCLEROSTOMYApril 2023August 2024Allow1710NoNo
18295333SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSApril 2023July 2023Allow410YesNo
18026996GONIOTOMY DEVICES WITH FLUID INGRESS/EGRESS CONTROLMarch 2023January 2026Abandon3410NoNo
18120262SYSTEM FOR PRODUCING A GRAFT DEVICE WITH A THREE DIMENSIONAL COVERINGMarch 2023April 2024Allow1400NoNo
18120260SYSTEM FOR PRODUCING A GRAFT DEVICE WITH A THREE DIMENSIONAL COVERINGMarch 2023June 2024Allow1500YesNo
18180016SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSMarch 2023July 2023Allow410NoNo
18167757SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSFebruary 2023July 2023Allow510NoNo
18019484A male urinary incontinence deviceFebruary 2023December 2025Abandon3510NoNo
18019445MULTI-CANISTER MODULE FOR NEGATIVE-PRESSURE THERAPYFebruary 2023September 2025Allow3120NoNo
18149394SENSING CANNULA SYSTEMSJanuary 2023July 2024Allow1821NoNo
18089318CATHETER SYSTEM CLAMP, SYSTEMS, AND METHODSDecember 2022August 2023Allow810NoNo
18088282FLUID MANAGEMENT DEVICE AND SYSTEMDecember 2022January 2024Allow1320YesNo
18069698PORTABLE EYEWASH EYEPIECEDecember 2022March 2026Abandon3920NoNo
18008714NEGATIVE PRESSURE WOUND THERAPY DEVICE WITH OXYGEN CONTROLDecember 2022February 2026Allow3830NoYes
18061286FORMING A SEALED PACKAGE WITH A FROZEN ALIQUOTDecember 2022March 2026Abandon3910NoNo
18056042MEDICAL DEVICE DISLODGMENT DETECTIONNovember 2022January 2024Allow1410YesNo
17986141EXTRACORPOREAL BLOOD TREATMENT APPARATUSNovember 2022August 2023Allow910NoNo
17925070APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENTNovember 2022January 2026Allow3810NoNo
17985051NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES AND METHODS WITH INTEGRATED ELECTRONICSNovember 2022January 2024Allow1420YesNo
17924049SELF-ADHESIVE PATCHES MADE OF FIBRES FOR THE CONTROLLED RELEASE OF BIOACTIVESNovember 2022June 2025Allow3100NoNo
17922427DETECTION DEVICE FOR SMART ABSORBENT ARTICLESOctober 2022October 2025Abandon3610NoNo
17976711SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSOctober 2022September 2023Allow1120YesNo
17921523CANNULA INSERTION SYSTEM AND METHODS OF USING THE SAMEOctober 2022January 2026Allow3810NoNo
17919700DUAL MODE NEGATIVE PRESSURE SOURCE OPERATION FOR PROVISION OF NEGATIVE PRESSURE WOUND THERAPYOctober 2022December 2024Allow2610NoNo
17915711BLOOD PURIFICATION SYSTEM, CONTROLLING METHOD, CONTROLLING PROGRAM, LEARNING DEVICE, AND LEARNING METHODSeptember 2022November 2025Abandon3810NoNo
17950190DRAIN TRAY ASSEMBLY, SYSTEM AND METHODSeptember 2022April 2024Allow1920YesNo
17883225PORTABLE DEVICE WITH DISPOSABLE RESERVOIR FOR COLLECTION OF INTERNAL FLUID AFTER SURGERY FROM A PLURALITY OF SITES SIMULTANEOUSLYAugust 2022July 2024Allow2310NoNo
17797522INNOVATIVE DEVICE FOR VASCULAR ACCESS IN A DIALYSIS TREATMENTAugust 2022June 2025Allow3410NoNo
17865280SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJuly 2022November 2022Allow410NoNo
17865315SYSTEM FOR TREATING EMBOLISM AND ASSOCIATED DEVICES AND METHODSJuly 2022March 2023Allow820YesNo
17792742BASE PLATE FOR AN OSTOMY APPLIANCEJuly 2022October 2025Allow3920YesNo
17811150INFUSION CANNULAJuly 2022September 2023Allow1410NoNo
17840289THERAPEUTIC EYE MASKJune 2022January 2026Allow4420NoNo
17783857An Anti-Microbial Coated Urethral Plug for CAUTI ReductionJune 2022February 2026Abandon4520NoNo
17826201ABSORBENT ARTICLE COMPRISING AN INTERMEDIATE LAYERMay 2022February 2026Abandon4421NoNo
17748934NEGATIVE-PRESSURE TREATMENT WITH AREA STABILIZATIONMay 2022March 2025Abandon3440NoNo
17774731KIT FOR OPHTHALMIC SOLUTIONS IN SCREW-CAP DROPPER BOTTLESMay 2022August 2024Allow2810NoNo
17717698NEGATIVE PRESSURE WOUND DRESSINGApril 2022July 2025Abandon3940NoNo
17697108Connector with Valve for Negative Pressure Wound Therapy SystemMarch 2022May 2023Allow1410NoNo
17690064MULTIPLE-WOUND NEGATIVE PRESSURE WOUND THERAPY USING MULTIPLE FLUID COLLECTION VOLUMESMarch 2022June 2023Allow1510NoNo
17640011Negative Pressure Charged Vibration Mechanism For Intermittent Wound Dressing VibrationMarch 2022January 2026Allow4720NoNo
17636647ASSEMBLY COMPRISING A TRANSFER TOOL, AND TRANSFER TOOLFebruary 2022March 2025Allow3700YesNo
17500136DRESSING WITH VARIABLE CONTRACTION ZONESOctober 2021June 2024Allow3210YesNo
17498501MULTIPLE DRESSING NEGATIVE PRESSURE WOUND THERAPY SYSTEMOctober 2021September 2023Allow2310NoNo
17487542SYSTEMS AND METHODS FOR APPLYING REDUCED PRESSURE THERAPYSeptember 2021July 2024Abandon3320NoNo
17478735FLUID REMOVAL MANAGEMENT AND CONTROL OF WOUND CLOSURE IN WOUND THERAPYSeptember 2021April 2023Allow1900NoNo
17478403APPARATUSES AND METHODS FOR WOUND THERAPYSeptember 2021June 2024Allow3210NoNo
17475471FLUID COLLECTION DEVICE, RELATED APPARATUS AND METHOD OF USING THE SAMESeptember 2021December 2024Abandon3930NoYes
17469029Medical Tubing Arrangement Comprising a ValveSeptember 2021November 2023Abandon2610NoNo
17466539ADJUSTABLE NECK CATHETERSeptember 2021August 2023Allow2310NoNo
17430169FORWARD OSMOSIS MEDICAL AND WOUND CARE DEVICESAugust 2021February 2025Allow4220NoNo
17363533INTRAOCULAR IRRIGATION FLUID TEMPERATURE MODULATOR SYSTEM AND METHOD OF USING THE SAMEJune 2021January 2025Abandon4320NoNo
17343157NASAL SMOKE EVACUATORJune 2021September 2024Abandon3910NoNo
17341721ARTIFICIAL STOMA DEVICEJune 2021April 2025Abandon4610NoNo
17299177WOUND BASED SENSOR SYSTEM WITH AMBIENT ATMOSPHERE MONITORINGJune 2021November 2022Allow1710NoNo
17298864A Medical Waste Management System Integrated Within A Medical FacilityJune 2021March 2025Allow4632YesNo
17326980FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE INFLATION DEVICE AND METHODS AND SYSTEMS OF USING THE SAMEMay 2021January 2024Allow3211NoNo
17292917APPARATUS, SYSTEM, AND METHOD FOR MECHANICAL INDICATION OF PRESSUREMay 2021May 2022Allow1210NoNo
17237559Adhesive For An Absorbent ArticleApril 2021May 2024Allow3720NoNo
17283396NEGATIVE PRESSURE DEVICE INCLUDING EXPANDABLE SEGMENTApril 2021September 2022Allow1710NoNo
17191424Negative Pressure Wound Therapy Instillation SystemMarch 2021October 2023Allow3111NoNo
17185631ISOLATING DRAINAGE CATHETERFebruary 2021December 2022Allow2210YesNo
17174467PROTECTIVE SLEEVE FOR FINGERS AND TOESFebruary 2021September 2023Abandon3110NoNo
17166772PORTABLE URINAL DEVICEFebruary 2021January 2023Allow2420NoNo
17165187APPARATUS AND SYSTEM FOR REDUCING VACCUM PUMP NOISEFebruary 2021November 2022Allow2220NoNo
17259273WOUND THERAPY SYSTEM WITH CONDUIT BLOCKAGE DETECTIONJanuary 2021March 2024Allow3930NoNo
17118245SYSTEMS AND DEVICES, AND METHODS FOR REPLACING AN EYE DROPPER TIP ON AN EYEDROPPER BOTTLE WITH A REPLACEMENT EYEDROPPER TIPDecember 2020February 2023Allow2600NoNo
17091227COLLECTING UNIT FOR MEDICAL SUCTIONS WITH A FOLDED BAGNovember 2020July 2023Allow3211NoNo
17085355Micro-dosing Oil DispenserOctober 2020May 2022Abandon1810NoNo
17050504SENSING CANNULA SYSTEMSOctober 2020August 2022Allow2211NoNo
17045358COMPRESSION STRAIN AND NEGATIVE PRESSURE DELIVERY INDICATOR FOR A WOUND DRESSINGOctober 2020March 2022Allow1810NoNo
17040377SYSTEM FOR MANAGING INSTILLATION THERAPY ON MULTIPLE WOUNDS WITH A SINGLE FLUID SOURCESeptember 2020June 2022Allow2011NoNo
17022633Blood Purification Apparatus and Method of Trapping Bubbles ThereinSeptember 2020March 2024Allow4220YesNo
17010661SYSTEM AND METHOD FOR AUTOMATICALLY ADJUSTING AN EXTERNAL VENTRICULAR DRAINSeptember 2020November 2022Allow2710NoNo
16969303SURGICAL GAUZEAugust 2020January 2023Allow2910NoNo
16966763APPARATUS FOR SECURING DEVICE COUPLINGSJuly 2020July 2024Allow4810NoNo
16936053GLAUCOMA AQUEOUS HUMOR DRAINAGE DEVICE AND GLAUCOMA AQUEOUS HUMOR DRAINAGE METHODJuly 2020July 2022Allow2420YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RASSAVONG, ERIC.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
1
(33.3%)
Not Allowed After Appeal Filing
2
(66.7%)
Filing Benefit Percentile
55.5%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner RASSAVONG, ERIC - Prosecution Strategy Guide

Executive Summary

Examiner RASSAVONG, ERIC works in Art Unit 3781 and has examined 111 patent applications in our dataset. With an allowance rate of 77.5%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.

Allowance Patterns

Examiner RASSAVONG, ERIC's allowance rate of 77.5% places them in the 44% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by RASSAVONG, ERIC receive 1.58 office actions before reaching final disposition. This places the examiner in the 30% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by RASSAVONG, ERIC is 31 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +29.4% benefit to allowance rate for applications examined by RASSAVONG, ERIC. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 31.9% of applications are subsequently allowed. This success rate is in the 66% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 38.2% of cases where such amendments are filed. This entry rate is in the 58% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 88.9% are granted (fully or in part). This grant rate is in the 88% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.